The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit
Crossref DOI link: https://doi.org/10.1007/s13300-019-00686-z
Published Online: 2019-08-27
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patel, Dhiren K.
Strong, Jodi
Funding for this research was provided by:
AstraZeneca
Article History
Received: 3 July 2019
First Online: 27 August 2019